echinacea
one
commonli
use
herbal
product
controversi
exist
benefi
prevent
treatment
common
cold
thu
metaanalysi
evalu
eff
ect
echinacea
incid
durat
common
cold
uniqu
studi
includ
metaanalysi
incid
common
cold
report
odd
ratio
ci
durat
common
cold
report
weight
mean
diff
erenc
wmd
ci
weight
averag
mean
diff
erenc
calcul
randomeff
ect
model
dersimonianlaird
methodolog
heterogen
assess
q
statist
review
plot
public
bia
assess
egger
weight
regress
statist
visual
inspect
funnel
plot
echinacea
decreas
odd
develop
common
cold
ci
q
statist
p
durat
cold
day
wmd
similarli
signifi
cant
reduct
maintain
subgroup
analys
limit
echinaguardechinacin
use
concomit
supplement
use
method
cold
exposur
jadad
score
less
use
fi
xedeff
ect
model
publish
evid
support
echinacea
benefi
decreas
incid
durat
common
cold
accord
nation
institut
allergi
infecti
diseas
us
popul
billion
cold
annual
adult
two
four
cold
per
year
wherea
children
six
ten
cold
although
rhinoviru
coronaviru
common
virus
precipit
cold
symptom
approxim
virus
also
known
caus
common
cold
usa
lost
work
time
time
lost
school
attribut
symptom
caus
common
cold
common
cold
also
associ
larg
fi
nancial
burden
societi
us
billion
spent
annual
physician
visit
anoth
billion
spent
nonprescript
cough
cold
treatment
approxim
adult
us
popul
use
nutraceut
herbal
product
function
food
anim
base
supplement
echinacea
collect
nine
relat
plant
speci
indigen
north
america
common
nutraceut
use
consum
peopl
echinacea
angustifolia
echinacea
pallida
echinacea
purpurea
fi
gure
common
speci
recognis
medicin
valu
mechan
action
underli
propos
immunostimulatori
eff
ect
echinacea
remain
unclear
evid
suggest
upregul
tumour
necrosi
mrna
stimul
agonist
activ
cannabinoid
receptor
alkamid
present
echinacea
role
german
commiss
e
canadian
natur
health
product
director
advoc
echinacea
use
common
cold
howev
controversi
effi
caci
echinacea
prevent
treatment
common
cold
studi
show
benefi
other
show
null
eff
ect
metaanalysi
use
situat
sinc
show
preponder
evid
publish
work
suggest
past
systemat
review
melchart
colleagu
conclud
echinacea
prepar
aerial
part
plant
eff
ectiv
treatment
cold
evid
prevent
cold
lack
import
note
howev
review
exclud
studi
use
experiment
rhinoviru
infect
echinacea
prepar
supplement
includ
recent
studi
turner
colleagu
therefor
metaanalysi
evalu
eff
ect
echinacea
incid
durat
common
cold
randomis
placebocontrol
studi
literatur
search
use
term
echinacea
purpl
conefl
ower
limit
human
be
clinic
trial
done
three
independ
review
sa
cmw
cic
use
medlin
april
trial
includ
analysi
met
follow
inclus
criteria
randomis
placebocontrol
trial
evalu
echinaceacontain
product
prevent
andor
treatment
common
cold
adequ
report
data
either
cold
incid
durat
case
studi
evalu
eff
ect
diff
erent
echinacea
speci
formul
compar
placebo
possibl
data
echinacea
arm
pool
compar
placebo
arm
data
report
separ
bacteri
viral
infect
latter
extract
inclus
analysi
follow
methodolog
featur
relev
control
bia
assess
randomis
random
alloc
conceal
mask
treatment
alloc
blind
withdraw
jadad
score
calcul
aid
identifi
cation
report
overal
weaker
studi
methodolog
studi
review
evalu
three
independ
review
sa
cmw
cic
disagr
resolv
consensu
data
independ
abstract
three
investig
sa
cmw
cic
use
standardis
data
abstract
tool
follow
inform
sought
articl
author
identifi
cation
year
public
geograph
locat
studi
studi
fund
sourc
type
studi
design
prospect
retrospect
randomis
observ
presenc
type
control
blind
openlabel
studi
popul
sampl
size
durat
patient
followup
echinacea
product
use
specifi
c
speci
dose
prepar
type
brand
unbrand
presenc
absenc
concomitantli
administ
supplement
mode
viru
exposur
natur
inocul
defi
nition
incid
durat
cold
report
incid
common
cold
treat
dichotom
variabl
report
odd
ratio
ci
use
dersimonian
laird
randomeff
ect
model
calcul
odd
ratio
problemat
absenc
event
one
compar
group
studi
nomin
valu
cold
ad
cell
enabl
calcul
odd
ratio
risk
diff
erenc
also
calcul
aid
assess
statist
clinic
signifi
canc
well
durat
ill
treat
continu
variabl
weight
mean
diff
erenc
wmd
calcul
diff
erenc
mean
day
common
cold
echinacea
control
group
dersimonian
laird
randomeff
ect
model
use
calcul
weight
mean
diff
erenc
ci
one
studi
provid
ci
continu
data
studi
standard
deviat
mean
calcul
ci
use
standard
method
statist
heterogen
address
use
q
statist
p
consid
signifi
cant
heterogen
also
assess
visual
inspect
plot
statist
analys
done
use
statsdirect
version
statsdirect
ltd
cheshir
uk
numer
subgroup
analys
assess
sourc
clinic
heterogen
done
concomit
administr
addit
nutraceut
echinacea
could
potenti
result
synergist
addit
inhibitori
interact
therefor
echinacea
effi
caci
assess
presenc
absenc
nutraceut
lack
regul
herbal
product
concern
arisen
regard
content
analys
includ
studi
incid
echinacea
group
incid
control
group
turner
et
al
incid
furthermor
nine
standardis
prepar
met
qualiti
standard
describ
label
five
studi
metaanalysi
includ
e
purpurea
product
extract
alcohol
echinaguard
echinacin
madau
ag
cologn
germani
analysi
benefi
use
two
product
done
subgroup
final
studi
includ
metaanalysi
examin
patient
expos
contract
cold
either
natur
investig
inocul
sinc
eff
ect
might
effi
caci
echinacea
known
separ
analys
done
evalu
studi
use
natur
investigatorinocul
viru
studi
poorer
methodolog
qualiti
unblind
openlabel
trial
might
exhibit
exagger
treatment
eff
ect
exclud
might
result
increas
intern
valid
could
reduc
extern
valid
analysi
addit
select
random
versu
fi
xedeff
ect
model
metaanalys
controversi
use
randomeff
ect
model
calcul
confi
denc
interv
result
wider
interv
thu
conserv
estim
treatment
eff
ect
compar
fi
xedeff
ect
model
reconcil
issu
sensit
analysi
done
metaanalysi
reanalys
exclud
studi
weaker
methodolog
jadad
score
less
use
fi
xedeff
ect
model
mantelhaenszel
methodolog
egger
weight
regress
statist
visual
inspect
funnel
plot
use
assess
presenc
public
bia
studi
identifi
cation
inclus
exclus
shown
fi
gure
initi
search
strategi
yield
citat
turner
cohen
sperber
schulten
turner
grimm
berg
melchart
hoheisel
combin
random
odd
ratio
ci
exclud
manual
electron
limit
search
human
be
clinic
trial
remain
abstract
review
exclud
evalu
echinacea
outcom
cold
incid
durat
therefor
abstract
remain
underw
fulltext
articl
review
eight
studi
report
data
either
primari
endpoint
analysi
incid
durat
one
use
activ
control
therefor
uniqu
studi
therefor
includ
metaanalysi
encompass
studi
particip
incid
particip
durat
tabl
show
characterist
includ
studi
seven
studi
evalu
monotherapi
e
purpurea
one
studi
evalu
e
angustifolia
one
evalu
e
pallida
one
studi
specifi
specifi
c
speci
echinacea
studi
four
studi
evalu
combin
diff
erent
echinacea
speci
two
studi
evalu
echinacea
eff
ect
children
five
studi
use
either
echinaguard
echinacin
product
made
one
compani
madau
ag
viru
exposur
use
rhinoviru
inocul
done
three
studi
four
studi
evalu
eff
ect
echinacea
along
supplement
summari
individu
studi
data
incid
durat
cold
provid
tabl
metaanalysi
show
echinacea
decreas
odd
patient
contract
cold
odd
ratio
ci
q
statist
p
correspond
risk
diff
erenc
number
need
treat
echinacea
also
found
decreas
durat
cold
day
wmd
shown
fi
gure
fi
gure
q
statist
show
signifi
cant
heterogen
incid
durat
analys
howev
review
plot
incid
show
includ
studi
gener
agre
echinacea
posit
eff
ect
magnitud
benefi
fi
gure
degre
asymmetri
note
upon
review
funnel
plot
incid
durat
analys
result
inabl
rule
presenc
public
bia
analys
fi
gure
howev
public
bia
assess
use
egger
weight
regress
statist
signifi
cant
public
bia
detect
either
incid
durat
analys
respect
tabl
depict
result
subgroup
sensit
analys
regardless
whether
echinacea
administ
presenc
absenc
supplement
nutraceut
substanti
reduct
incid
common
cold
seen
wherea
subgroup
receiv
echinacea
supplement
show
signifi
cant
eff
ect
short
durat
cold
right
p
subgroup
receiv
echinacea
without
supplement
show
trend
toward
benefi
analysi
limit
fi
studi
evalu
echinaguard
echinacin
product
similar
signifi
cant
reduct
patient
odd
compar
overal
analysi
observ
reduct
odd
contract
cold
observ
viru
exposur
occur
natur
investig
inocul
decreas
durat
cold
also
maintain
natur
viru
exposur
studi
evalu
endpoint
cold
durat
studi
use
echinaguardechinacin
evalu
investig
rhinoviru
inocul
thu
analys
could
undertaken
final
neither
use
fi
xedeff
ect
model
instead
randomeff
ect
model
exclus
studi
jadad
score
less
eff
ect
overal
studi
conclus
product
contain
echinacea
avail
come
tablet
extract
fresh
juic
tinctur
tea
formul
three
commonli
use
speci
echinacea
diff
ere
part
plant
use
diff
erent
product
fl
ower
stem
root
plant
speci
may
contain
diff
ere
level
constitu
molecul
diff
erent
part
year
geograph
locat
although
concentr
varianc
exist
three
speci
echinacea
contain
watersolubl
polysaccharid
lipophil
fraction
alkamid
polyacetylen
caff
eoyl
conjug
echinacosid
chicor
acid
caff
eic
acid
fl
avonoid
yet
determin
one
combin
eff
ect
mani
constitu
mainli
alkamid
chicor
acid
polysaccharid
induc
immunostimul
despit
factor
infl
uenc
effi
caci
echinacea
diff
erent
dose
review
use
result
metaanalysi
show
echinacea
reduc
incid
well
durat
common
cold
sinc
echinaguard
echinacin
product
contain
fresh
press
juic
e
purpurea
alcohol
extract
manufactur
compani
evalu
fi
diff
erent
studi
analys
benefi
ts
product
separ
found
reduct
incid
cold
might
import
sinc
variabl
echinacea
product
evalu
trial
would
minimis
metaanalysi
one
cold
incid
studi
use
echinacea
supplement
vitamin
c
propoli
studi
found
reduct
incid
common
cold
determin
combin
echinacea
nutraceut
yield
better
result
echinacea
alon
sever
experiment
studi
shown
vitamin
c
might
eff
ect
immun
system
propoli
natur
resin
product
collect
honeybe
variou
plant
sourc
also
use
prevent
respiratori
infect
cold
durat
outcom
four
studi
use
echinacea
combin
addit
supplement
vitamin
c
propoli
lemongrass
leaf
spearmint
peppermint
thyme
citric
acid
rosemari
leaf
eucalyptu
fennel
seed
yield
shorter
durat
cold
placebo
echinacea
use
alon
although
show
similar
benefi
show
signifi
cantli
shorter
durat
cold
placebo
suggest
subgroup
analysi
underpow
compar
result
durat
cold
overal
analysi
subgroup
analys
suggest
benefi
caus
echinacea
rather
supplement
evalu
method
viral
exposur
outcom
cold
induct
echinacea
given
prophylact
attempt
reduc
incid
natur
cold
induct
incid
reduc
versu
placebo
echinacea
given
prophylaxi
cold
induct
caus
direct
rhinoviru
inocul
incid
reduc
one
postul
possibl
reduc
benefi
ts
direct
inocul
echinacea
work
better
prevent
common
cold
caus
virus
rhinoviru
virus
capabl
caus
common
cold
echinacea
could
modest
eff
ect
rhinoviru
mark
eff
ect
virus
direct
rhinoviru
inocul
trial
tout
studi
turner
colleagu
publish
author
compar
patient
given
e
angustifolia
equival
mgday
placebo
show
echinacea
clinic
signifi
cant
eff
ect
infect
rhinoviru
clinic
ill
result
german
commiss
e
approv
e
purpurea
recommend
dose
mg
approv
e
angustifolia
monograph
recommend
e
angustifolia
dose
g
dose
three
time
dose
use
turner
colleagu
dose
use
trial
may
low
fulli
eff
ectiv
previou
metaanalysi
done
melchart
colleagu
updat
novemb
includ
trial
encompass
analys
show
benefi
echinacea
treatment
prevent
common
cold
comparison
metaanalysi
includ
trial
encompass
analys
although
result
agreement
previou
metaanalysi
result
suggest
addit
benefi
echinacea
use
prevent
well
treatment
cold
metaanalysi
lind
colleagu
assess
cold
sever
endpoint
includ
two
unpublish
evalu
exclud
studi
use
experiment
rhinoviru
inocul
combin
echinacea
nutraceut
ingredi
analysi
chose
evalu
cold
sever
concern
potenti
heterogen
method
use
cold
sever
assess
studi
includ
studi
evalu
echinacea
nutraceut
analysi
well
studi
evalu
direct
rhinoviru
inocul
highest
intern
valid
sinc
viru
degre
exposur
exact
time
exposur
known
decid
address
eff
ect
potenti
confound
use
subgroup
sensit
analys
rather
exclus
provid
inform
make
determin
effi
caci
echinacea
furthermor
includ
one
studi
publish
melchart
colleagu
updat
analysi
exclud
unpublish
studi
data
studi
undergon
rigor
peer
review
sever
limit
metaanalysi
must
address
first
studi
barrett
turner
colleagu
use
alfalfa
mixtur
alcohol
beverag
respect
placebo
arm
sinc
alfalfa
alcohol
concoct
may
immunostimulatori
benefi
ts
use
placebo
arm
controversi
although
agre
may
potenti
confound
analys
note
agent
fact
benefi
cial
properti
reduc
incid
andor
durat
common
cold
would
result
underestim
echinacea
benefi
second
although
egger
statist
show
absenc
public
bia
funnel
plot
show
asymmetri
suggest
potenti
public
bia
elimin
public
bia
aris
trial
neg
outcom
lower
propens
publish
third
heterogen
present
metaanalysi
howev
plot
show
heterogen
result
studi
disagr
magnitud
direct
echinacea
benefi
furthermor
variou
subgroup
analys
assess
eff
ect
clinic
heterogen
echinacea
maintain
signifi
cant
eff
ect
reduct
cold
incid
durat
final
analysi
focus
effi
caci
safeti
echinacea
although
advers
event
echinacea
commonli
report
gastrointestin
upset
rash
report
much
work
need
done
elucid
safeti
prolong
therapi
sinc
eff
ect
ratecorrect
qt
interv
blood
pressur
safeti
paramet
well
known
note
echinacea
human
cytochrom
enzym
inhibitor
potenti
drug
interact
also
need
assess
analysi
current
evid
literatur
suggest
echinacea
benefi
decreas
incid
durat
common
cold
howev
largescal
randomis
prospect
studi
control
variabl
speci
qualiti
prepar
dose
echinacea
method
cold
induct
object
studi
endpoint
evalu
need
echinacea
prevent
treatment
common
cold
becom
standard
practic
declar
confl
ict
interest
describ
detail
method
section
page
